Coronary bifurcation lesions are a challenging lesion subset of coronary
artery obstructive diseases. With the rapid development of stent
platforms, drug-coating techniques, a new generation of antiplatelet
therapeutic drugs, intravascular imaging, and a better understanding of
the abnormal flow dynamics around bifurcated areas, patients after
stenting of coronary bifurcation lesions have shown a dramatic reduction
in major adverse cardiac events (MACE). In the last decade, the
European Bifurcation Club, a leading educational platform, has attempted
to improve clinical outcomes in patients with coronary bifurcation
lesions, as reflected in the annual updated consensus document.
Other similar groups have emerged (...